{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T09:05:20Z","timestamp":1790931920796,"version":"4.1.0"},"reference-count":85,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.mdpi.com"],"crossmark-restriction":true},"short-container-title":["Life"],"abstract":"<jats:p>5-Aminolevulinic acid (5-ALA) is used clinically for photodynamic therapy and fluorescence-guided diagnosis and surgery due to its selective accumulation in malignant cells, where it is converted into photoactive protoporphyrin IX (PpIX) via the heme biosynthesis pathway. The resulting buildup allows for selective visualization or destruction of the tissue under specific light exposure, particularly in pre-malignant and malignant skin lesions, brain tumors, and bladder cancer. More recently, 5-ALA and 5-ALA-induced PpIX have attracted interest for emerging diagnostic and therapeutic approaches. For instance, PpIX is being investigated as a potential marker for liquid biopsy. PpIX-mediated photodynamic therapy also shows promise for targeting specific cancer cell populations, including dormant cancer cells and cancer stem cells. In addition, the benefits of 5-ALA in neurological and mental health are under investigation, as disruptions in heme biosynthesis are increasingly linked to neurodegenerative diseases, chronic fatigue, and mood and sleep disorders. This review highlights these expanding research directions, discusses current challenges, and explores potential opportunities for 5-ALA-based applications.<\/jats:p>","DOI":"10.3390\/life15101516","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T10:39:37Z","timestamp":1758883177000},"page":"1516","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Protoporphyrin IX Beyond Conventional Applications: A Review of Emerging Research Directions"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3383-7782","authenticated-orcid":false,"given":"Mustafa Kemal","family":"Ruhi","sequence":"first","affiliation":[{"name":"Institute of Biomedical Engineering, Bo\u011fazi\u00e7i University, Istanbul 34342, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"85007","DOI":"10.1117\/1.JBO.19.8.085007","article-title":"Real-time analysis of endogenous protoporphyrin IX fluorescence from delta-aminolevulinic acid and its derivatives reveals distinct time- and dose-dependent characteristics in vitro","volume":"19","author":"Kiesslich","year":"2014","journal-title":"J. Biomed. Opt."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"25865","DOI":"10.3390\/ijms161025865","article-title":"Aminolevulinic Acid-Based Tumor Detection and Therapy: Molecular Mechanisms and Strategies for Enhancement","volume":"16","author":"Yang","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2174\/1568011043352984","article-title":"On the selectivity of 5-aminolevulinic acid-induced protoporphyrin IX formation","volume":"4","author":"Collaud","year":"2004","journal-title":"Curr. Med. Chem. Anticancer Agents"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"4140","DOI":"10.3390\/molecules16054140","article-title":"Aminolevulinic Acid (ALA) as a Prodrug in Photodynamic Therapy of Cancer","volume":"16","author":"Wachowska","year":"2011","journal-title":"Molecules"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e201900022","DOI":"10.1002\/tbio.201900022","article-title":"Fundamentals of 5-aminolevulinic acid photodynamic therapy and diagnosis: An overview","volume":"2","author":"Malik","year":"2020","journal-title":"Transl. Biophotonics"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.pdpdt.2013.02.001","article-title":"Expression levels of PEPT1 and ABCG2 play key roles in 5-aminolevulinic acid (ALA)-induced tumor-specific protoporphyrin IX (PpIX) accumulation in bladder cancer","volume":"10","author":"Hagiya","year":"2013","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s10147-020-01766-y","article-title":"Key transporters leading to specific protoporphyrin IX accumulation in cancer cell following administration of aminolevulinic acid in photodynamic therapy\/diagnosis","volume":"26","author":"Lai","year":"2021","journal-title":"Int. J. Clin. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"115851","DOI":"10.1016\/j.bcp.2023.115851","article-title":"Targeting ABCG2 transporter to enhance 5-aminolevulinic acid for tumor visualization and photodynamic therapy","volume":"217","author":"Chandratre","year":"2023","journal-title":"Biochem. Pharmacol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Otsuka, S., Matsumoto, K., Nakajima, M., Tanaka, T., and Ogura, S. (2015). Oxygen Availability for Porphyrin Biosynthesis Enzymes Determines the Production of Protoporphyrin IX (PpIX) during Hypoxia. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0146026"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"103056","DOI":"10.1016\/j.pdpdt.2022.103056","article-title":"The effect of hypoxia on photodynamic therapy with 5-aminolevulinic acid in malignant gliomas","volume":"40","author":"Ihata","year":"2022","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0304-3835(96)04558-2","article-title":"The pH dependency of protoporphyrin IX formation in cells incubated with 5-aminolevulinic acid","volume":"113","author":"Bech","year":"1997","journal-title":"Cancer Lett."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/(SICI)1096-9101(1999)24:4<296::AID-LSM7>3.0.CO;2-F","article-title":"Comparative study on the ALA photodynamic effects of human glioma and meningioma cells","volume":"24","author":"Tsai","year":"1999","journal-title":"Lasers Surg. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/1011-1344(92)85108-7","article-title":"Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy","volume":"14","author":"Kennedy","year":"1992","journal-title":"J. Photochem. Photobiol. B"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0021-9258(18)64861-6","article-title":"Further studies on the utilization of delta-aminolevulinic acid for porphyrin synthesis","volume":"225","author":"Schiffmann","year":"1957","journal-title":"J. Biol. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s11060-019-03098-y","article-title":"5-ALA and FDA approval for glioma surgery","volume":"141","author":"Hadjipanayis","year":"2019","journal-title":"J. Neuro-Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/lsm.22933","article-title":"5-ALA in the management of malignant glioma","volume":"50","author":"Stepp","year":"2018","journal-title":"Lasers Surg. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1039\/b712847a","article-title":"ALA and its clinical impact, from bench to bedside","volume":"7","author":"Krammer","year":"2008","journal-title":"Photochem. Photobiol. Sci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1615\/JEnvironPatholToxicolOncol.v26.i2.110","article-title":"ALA and malignant glioma: Fluorescence-guided resection and photodynamic treatment","volume":"26","author":"Stepp","year":"2007","journal-title":"J. Environ. Pathol. Toxicol. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S1470-2045(06)70665-9","article-title":"Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: A randomised controlled multicentre phase III trial","volume":"7","author":"Stummer","year":"2006","journal-title":"Lancet Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Kim, T.E., and Chang, J.E. (2023). Recent Studies in Photodynamic Therapy for Cancer Treatment: From Basic Research to Clinical Trials. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15092257"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/jdv.12031","article-title":"European guidelines for topical photodynamic therapy part 1: Treatment delivery and current indications-actinic keratoses, Bowen\u2019s disease, basal cell carcinoma","volume":"27","author":"Morton","year":"2013","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/j.juro.2010.06.148","article-title":"Hexaminolevulinate guided fluorescence cystoscopy reduces recurrence in patients with nonmuscle invasive bladder cancer","volume":"184","author":"Stenzl","year":"2010","journal-title":"J. Urol."},{"key":"ref_23","first-page":"6682","article-title":"The cost-effectiveness of blue light cystoscopy in bladder cancer detection: United States projections based on clinical data showing 4.5 years of follow up after a single hexaminolevulinate hydrochloride instillation","volume":"20","author":"Garfield","year":"2013","journal-title":"Can. J. Urol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1177\/1756287217720401","article-title":"Optical improvements in the diagnosis of bladder cancer: Implications for clinical practice","volume":"9","author":"Schubert","year":"2017","journal-title":"Ther. Adv. Urol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/iju.13718","article-title":"Oral 5-aminolevulinic acid-mediated photodynamic diagnosis using fluorescence cystoscopy for non-muscle-invasive bladder cancer: A multicenter phase III study","volume":"25","author":"Nakai","year":"2018","journal-title":"Int. J. Urol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"101999","DOI":"10.1016\/j.pdpdt.2020.101999","article-title":"Real-world experience with 5-aminolevulinic acid for the photodynamic diagnosis of bladder cancer: Diagnostic accuracy and safety","volume":"32","author":"Yamamoto","year":"2020","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"10443","DOI":"10.3390\/ijms160510443","article-title":"5-ALA Fluorescence Image Guided Resection of Glioblastoma Multiforme: A Meta-Analysis of the Literature","volume":"16","author":"Eljamel","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Zhao, S., Wu, J., Wang, C., Liu, H., Dong, X., Shi, C., Shi, C., Liu, Y., Teng, L., and Han, D. (2013). Intraoperative fluorescence-guided resection of high-grade malignant gliomas using 5-aminolevulinic acid-induced porphyrins: A systematic review and meta-analysis of prospective studies. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0063682"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1002\/cncr.30088","article-title":"The role of 5-aminolevulinic acid in enhancing surgery for high-grade glioma, its current boundaries, and future perspectives: A systematic review","volume":"122","author":"Mansouri","year":"2016","journal-title":"Cancer"},{"key":"ref_30","first-page":"11","article-title":"Cancer diagnosis: From tumor to liquid biopsy and beyond","volume":"19","author":"Vaidyanathan","year":"2018","journal-title":"Lab Chip"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"De Angelis, M.L., Francescangeli, F., La Torre, F., and Zeuner, A. (2019). Stem Cell Plasticity and Dormancy in the Development of Cancer Therapy Resistance. Front. Oncol., 9.","DOI":"10.3389\/fonc.2019.00626"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/bs.acr.2018.12.002","article-title":"Dormancy and cancer stem cells: An enigma for cancer therapeutic targeting","volume":"141","author":"Talukdar","year":"2019","journal-title":"Adv. Cancer Res."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"GBD 2019 Mental Disorders Collaborators (2022). Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990\u20132019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet Psychiatry, 9, 137\u2013150.","DOI":"10.1016\/S2215-0366(21)00395-3"},{"key":"ref_34","unstructured":"GBD 2021 Nervous System Disorders Collaborators (2024). Global, regional, and national burden of disorders affecting the nervous system, 1990\u20132021: A systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol., 23, 344\u2013381."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Sequeira, L., Benfeito, S., Fernandes, C., Lima, I., Peixoto, J., Alves, C., Machado, C.S., Gaspar, A., Borges, F., and Chavarria, D. (2024). Drug Development for Alzheimer\u2019s and Parkinson\u2019s Disease: Where Do We Go Now?. Pharmaceutics, 16.","DOI":"10.20944\/preprints202404.0437.v1"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.freeradbiomed.2012.11.014","article-title":"Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease","volume":"62","author":"Yan","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e150","DOI":"10.1038\/emm.2014.122","article-title":"The role of mitochondrial DNA mutation on neurodegenerative diseases","volume":"47","author":"Cha","year":"2015","journal-title":"Exp. Mol. Med."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Chiabrando, D., Fiorito, V., Petrillo, S., and Tolosano, E. (2018). Unraveling the Role of Heme in Neurodegeneration. Front. Neurosci., 12.","DOI":"10.3389\/fnins.2018.00712"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Fiorito, V., Chiabrando, D., and Tolosano, E. (2018). Mitochondrial Targeting in Neurodegeneration: A Heme Perspective. Pharmaceuticals, 11.","DOI":"10.3390\/ph11030087"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Soladogun, A.S., and Zhang, L. (2024). The Neural Palette of Heme: Altered Heme Homeostasis Underlies Defective Neurotransmission, Increased Oxidative Stress, and Disease Pathogenesis. Antioxidants, 13.","DOI":"10.3390\/antiox13121441"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.neulet.2009.05.058","article-title":"Down-regulation of aminolevulinate synthase, the rate-limiting enzyme for heme biosynthesis in Alzheimer\u2019s disease","volume":"460","author":"Dwyer","year":"2009","journal-title":"Neurosci. Lett."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0197-4580(00)00112-3","article-title":"A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients","volume":"21","author":"Maurer","year":"2000","journal-title":"Neurobiol. Aging"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"16004","DOI":"10.1038\/s41598-020-72763-4","article-title":"Reduction of fatigue and anger-hostility by the oral administration of 5-aminolevulinic acid phosphate: A randomized, double-blind, placebo-controlled, parallel study","volume":"10","author":"Higashikawa","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4236\/ijcm.2013.410A001","article-title":"The Role of 5-Aminolevulinic Acid (5-ALA) and Sleep","volume":"4","author":"Perez","year":"2013","journal-title":"Int. J. Clin. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41572-024-00516-y","article-title":"Glioma","volume":"10","author":"Weller","year":"2024","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Qin, D., Yang, G., Jing, H., Tan, Y., Zhao, B., and Zhang, H. (2022). Tumor Progression and Treatment-Related Changes: Radiological Diagnosis Challenges for the Evaluation of Post Treated Glioma. Cancers, 14.","DOI":"10.3390\/cancers14153771"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/jmri.26306","article-title":"Perfusion MRI in treatment evaluation of glioblastomas: Clinical relevance of current and future techniques","volume":"49","author":"Smits","year":"2019","journal-title":"J. Magn. Reson. Imaging"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Maas, S.L.N., van Solinge, T.S., Schnoor, R., Yekula, A., Senders, J.T., de Vrij, J., Robe, P., Carter, B.S., Balaj, L., and Arkesteijn, G.J.A. (2020). Orally Administered 5-aminolevulinic Acid for Isolation and Characterization of Circulating Tumor-Derived Extracellular Vesicles in Glioblastoma Patients. Cancers, 12.","DOI":"10.3390\/cancers12113297"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e12278","DOI":"10.1002\/jev2.12278","article-title":"Glioblastoma-derived extracellular vesicle subpopulations following 5-aminolevulinic acid treatment bear diagnostic implications","volume":"11","author":"Hsia","year":"2022","journal-title":"J. Extracell. Vesicles"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"4297","DOI":"10.1038\/s41598-024-54478-y","article-title":"Protoporphyrin IX in serum of high-grade glioma patients: A novel target for disease monitoring via liquid biopsy","volume":"14","author":"Walke","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.pdpdt.2019.08.001","article-title":"Biosensor device for the photo-specific detection of immuno-captured bladder cancer cells using hexaminolevulinate: An ex-vivo study","volume":"28","author":"Chan","year":"2019","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"7283","DOI":"10.1038\/s41598-021-86649-6","article-title":"Improving hexaminolevulinate enabled cancer cell detection in liquid biopsy immunosensors","volume":"11","author":"Chan","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/978-1-4614-1445-2_8","article-title":"Tumor dormancy and cancer stem cells: Two sides of the same coin?","volume":"734","author":"Kleffel","year":"2013","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"36478","DOI":"10.1038\/srep36478","article-title":"Dormant cancer cells accumulate high protoporphyrin IX levels and are sensitive to 5-aminolevulinic acid-based photodynamic therapy","volume":"6","author":"Nakayama","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"7290","DOI":"10.1038\/s41598-021-86886-9","article-title":"Enhanced lipid metabolism induces the sensitivity of dormant cancer cells to 5-aminolevulinic acid-based photodynamic therapy","volume":"11","author":"Nakayama","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"104551","DOI":"10.1016\/j.pdpdt.2025.104551","article-title":"Highly malignant tumor cells accumulate less PpIX and enhanced cell dormancy increases PpIX accumulation","volume":"53","author":"Kasai","year":"2025","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Viana Cabral, F., Quilez Alburquerque, J., Roberts, H.J., and Hasan, T. (2024). Shedding Light on Chemoresistance: The Perspective of Photodynamic Therapy in Cancer Management. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25073811"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.canlet.2009.01.016","article-title":"Isolation and characterization of cancer stem like cells in human glioblastoma cell lines","volume":"279","author":"Qiang","year":"2009","journal-title":"Cancer Lett."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.pdpdt.2018.07.004","article-title":"5-Aminolevulinic acid-mediated photodynamic therapy can target human glioma stem-like cells refractory to antineoplastic agents","volume":"24","author":"Fujishiro","year":"2018","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"103119","DOI":"10.1016\/j.pdpdt.2022.103119","article-title":"Ablation efficacy of 5-aminolevulinic acid-mediated photodynamic therapy on human glioma stem cells","volume":"41","author":"Omura","year":"2023","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Yu, C.H., and Yu, C.C. (2014). Photodynamic therapy with 5-aminolevulinic acid (ALA) impairs tumor initiating and chemo-resistance property in head and neck cancer-derived cancer stem cells. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0087129"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"112552","DOI":"10.1016\/j.jphotobiol.2022.112552","article-title":"Effects of 5-ALA mediated photodynamic therapy in oral cancer stem cells","volume":"235","author":"Pinto","year":"2022","journal-title":"J. Photochem. Photobiol. B"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"4367","DOI":"10.1038\/s41598-025-88173-3","article-title":"Cancer stem cell populations are resistant to 5-aminolevulinic acid-photodynamic therapy (5-ALA-PDT)","volume":"15","author":"Rice","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Rickard, B.P., Conrad, C., Sorrin, A.J., Ruhi, M.K., Reader, J.C., Huang, S.A., Franco, W., Scarcelli, G., Polacheck, W.J., and Roque, D.M. (2021). Malignant Ascites in Ovarian Cancer: Cellular, Acellular, and Biophysical Determinants of Molecular Characteristics and Therapy Response. Cancers, 13.","DOI":"10.3390\/cancers13174318"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"E1974","DOI":"10.1073\/pnas.1216989110","article-title":"Flow induces epithelial-mesenchymal transition, cellular heterogeneity and biomarker modulation in 3D ovarian cancer nodules","volume":"110","author":"Rizvi","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/php.13209","article-title":"Photodynamic Therapy and the Biophysics of the Tumor Microenvironment","volume":"96","author":"Sorrin","year":"2020","journal-title":"Photochem. Photobiol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1038\/s42003-024-07268-1","article-title":"Mechanical forces inducing oxaliplatin resistance in pancreatic cancer can be targeted by autophagy inhibition","volume":"7","author":"Kalli","year":"2024","journal-title":"Commun. Biol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12940-023-01034-2","article-title":"Exposure to select PFAS and PFAS mixtures alters response to platinum-based chemotherapy in endometrial cancer cell lines","volume":"22","author":"Rickard","year":"2023","journal-title":"Environ. Health"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12940-020-00670-2","article-title":"Environmental chemicals, breast cancer progression and drug resistance","volume":"19","author":"Koual","year":"2020","journal-title":"Environ. Health"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1111\/php.14014","article-title":"PpIX-enabled fluorescence-based detection and photodynamic priming of platinum-resistant ovarian cancer cells under fluid shear stress","volume":"100","author":"Ruhi","year":"2024","journal-title":"Photochem. Photobiol."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Rickard, B.P., Sapienza-Lundie, L.A., Overchuk, M., Tan, X., Bae-Jump, V.L., Yates, M.S., Fenton, S.E., and Rizvi, I. (2025). Photodynamic priming overcomes platinum resistance from short-term exposure to select perfluoroalkyl substances in endometrial cancer cell lines. Photochem. Photobiol., 1\u201322.","DOI":"10.1111\/php.14073"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Nath, S., Pigula, M., Khan, A.P., Hanna, W., Ruhi, M.K., Dehkordy, F.M., Pushpavanam, K., Rege, K., Moore, K., and Tsujita, Y. (2020). Flow-induced Shear Stress Confers Resistance to Carboplatin in an Adherent Three-Dimensional Model for Ovarian Cancer: A Role for EGFR-Targeted Photoimmunotherapy Informed by Physical Stress. J. Clin. Med., 9.","DOI":"10.3390\/jcm9040924"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Rickard, B.P., Tan, X., Fenton, S.E., and Rizvi, I. (2022). Select Per- and Polyfluoroalkyl Substances (PFAS) Induce Resistance to Carboplatin in Ovarian Cancer Cell Lines. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23095176"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.bbamcr.2006.05.005","article-title":"Biosynthesis of heme in mammals","volume":"1763","author":"Ajioka","year":"2006","journal-title":"Biochim. Biophys. Acta (BBA)-Mol. Cell Res."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1080\/1028415X.2016.1199114","article-title":"Facilitation of brain mitochondrial activity by 5-aminolevulinic acid in a mouse model of Alzheimer\u2019s disease","volume":"20","author":"Omori","year":"2017","journal-title":"Nutr. Neurosci."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jphs.2020.07.012","article-title":"Neuroprotective effects of 5-aminolevulinic acid against neurodegeneration in rat models of Parkinson\u2019s disease and stroke","volume":"144","author":"Hijioka","year":"2020","journal-title":"J. Pharmacol. Sci."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"177658","DOI":"10.1016\/j.ejphar.2025.177658","article-title":"5-Aminolevulinic acid improves spatial recognition memory in mice","volume":"999","author":"Komiya","year":"2025","journal-title":"Eur. J. Pharmacol."},{"key":"ref_78","first-page":"1","article-title":"Introductory Chapter: GABA\/Glutamate Balance: A Key for Normal Brain Functioning","volume":"Volume 1","author":"Samardzic","year":"2018","journal-title":"GABA and Glutamate-New Developments in Neurotransmission Research"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1080\/25785826.2024.2445399","article-title":"A novel frameshift mutation in ADCK1 identified in a case of chronic fatigue syndrome successfully treated with oral 5-ALA\/SFC","volume":"48","author":"Koga","year":"2025","journal-title":"Immunol. Med."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/2211-5463.12048","article-title":"Combination of 5-aminolevulinic acid and ferrous ion reduces plasma glucose and hemoglobin A1c levels in Zucker diabetic fatty rats","volume":"6","author":"Hara","year":"2016","journal-title":"FEBS Open Bio"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1038\/s41598-017-03917-0","article-title":"Treatment of sarcopenia and glucose intolerance through mitochondrial activation by 5-aminolevulinic acid","volume":"7","author":"Fujii","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Saitoh, S., Okano, S., Nohara, H., Nakano, H., Shirasawa, N., Naito, A., Yamamoto, M., Kelly, V.P., Takahashi, K., and Tanaka, T. (2018). 5-aminolevulinic acid (ALA) deficiency causes impaired glucose tolerance and insulin resistance coincident with an attenuation of mitochondrial function in aged mice. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0189593"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1093\/hmg\/ddad092","article-title":"5-Aminolevulinic acid bypasses mitochondrial complex I deficiency and corrects physiological dysfunctions in Drosophila","volume":"32","author":"Nozawa","year":"2023","journal-title":"Hum. Mol. Genet."},{"key":"ref_84","unstructured":"Kingwill, A.C. (2024). A Randomised Control Trial of 5-Aminolevulinic Acid in Combination with Sodium Ferrous Citrate to Enhance Cardioprotection in Adults Undergoing Cardiac Surgery (TALEN). [Ph.D. Thesis, University of Oxford (United Kingdom)]."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"111477","DOI":"10.1016\/j.isci.2024.111477","article-title":"Therapeutic potential of 5-aminolevulinic acid in metabolic disorders: Current insights and future directions","volume":"27","author":"Kuryata","year":"2024","journal-title":"iScience"}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/15\/10\/1516\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T10:49:50Z","timestamp":1758883790000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/15\/10\/1516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":85,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["life15101516"],"URL":"https:\/\/doi.org\/10.3390\/life15101516","relation":{},"ISSN":["2075-1729"],"issn-type":[{"value":"2075-1729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]}}}